Testing removal of sentinel nodes after early stomach cancer procedure
Part of Cancer, Digestive system clinical trials.
This study compares two approaches after a non-curative ESD for early stomach cancer: one that removes sentinel lymph nodes (the first nodes where cancer might spread) and one that does not. Participating may help find out if removing these nodes improves outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have early stomach cancer that was removed with a procedure called endoscopic submucosal dissection (ESD)
- After that removal, your doctor found signs that the cancer might not be completely gone (for example, cancer cells in lymph or blood vessels, cancer at the deep edge, or deep invasion into the stomach wall)
- Your tumor is not too close to the top or bottom openings of the stomach
- You have not had radiation therapy to the upper belly before
- You are not pregnant and you don't have an allergy to the dye used in the procedure (ICG)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new image-guided method to find and remove sentinel lymph nodes (the first nodes where cancer might spread) in people with early stomach cancer. The goal is to precisely remove only the affected lymph nodes during surgery, which might mean a less extensive operation and fewer side effects.
This trial tests a combination of two surgical techniques for early-stage stomach cancer. It aims to remove the tumor and check nearby lymph nodes more precisely, which may help guide treatment and reduce side effects.
This trial tests a surgical technique that combines two types of minimally invasive procedures (laparoscopy and endoscopy) to find and remove the first lymph node that might contain cancer (called the sentinel lymph node) in people with early stomach cancer. The goal is to remove only the necessary lymph nodes, potentially reducing side effects while ensuring the cancer hasn't spread.
This trial tests a new technique that uses a special dye to highlight the first lymph nodes where stomach cancer might spread, allowing surgeons to remove only the necessary nodes during surgery. The goal is to reduce side effects while still effectively treating the cancer.
This trial compares two special camera methods (pCLE and EB) used during endoscopy to better see and diagnose early stomach changes. It may help doctors decide the best treatment for precancerous spots or very early cancer.
This study looks at early stomach cancer treated with ESD, a procedure to remove the tumor through the stomach lining, and how the depth of the scar relates to healing. It may help doctors predict better outcomes and improve the procedure for suitable patients.
Hear when a new Early Gastric Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.